<DOC>
	<DOC>NCT00348894</DOC>
	<brief_summary>The purpose of this study is to assess the long-term safety and tolerability of [S,S]-Reboxetine in patients with chronic painful diabetic peripheral neuropathy</brief_summary>
	<brief_title>[S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Diagnosis of type 1 or 2 diabetes mellitus, with painful, distal, symmetrical, sensorimotor polyneuropathy Patients at screening must have a score &gt;/=40 mm on the pain visual analogue scale Patients with significant hepatic impairment Patients with other severe pain, that may impair the selfassessment of the pain due to DPN</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>